Skip to main content
. 2018 Autumn;11(4):284–295.

Table 2.

Selection criteria for probiotic strains

Criteria Required properties
Safety Human or animal origin
Isolated from the gastrointestinal tract of healthy individuals
History of safe use
Precise diagnostic identification (phenotype and genotype traits)
Absence of data regarding an association with infective disease
Absence of the ability to cleave bile acid salts
No adverse effects
Absence of genes responsible for antibiotic resistance localized in non-stable elements
Functionality Competitiveness with respect to the microbiota inhabiting the intestinal ecosystem
Ability to survive and maintain the metabolic activity, and to grow in the target site
Resistance to bile salts and enzymes
Resistance to low pH in the stomach
Competitiveness with respect to microbial species inhabiting the intestinal ecosystem
Antagonistic activity towards pathogens
Resistance to bacteriocins and acids produced by the endogenic intestinal microbiota
Adherence and ability to colonize some particular sites within the host organism
An appropriate survival rate in the gastrointestinal system
Technological
usability
Easy production of high biomass amounts and high productivity of cultures
Viability and stability of the desired properties of probiotic bacteria during the fixing process
High storage survival rate in finished products
Guarantee of desired sensory properties of finished products
Genetic stability
Resistance to bacteriophages